Bernd STOWASSER, Head of European Public Private Partnerships at SANOFI Germany will join BioFIT as a speaker and discuss latest issues on Big consortia: how they work and what are their outcomes.
Many companies and research institutes are getting more and more involved in consortia of different sizes in order to work together around specific questions they are all looking to find an answer to. Of course their organization can be very different depending on the number of partners involved and the questions addressed. But how can their outcomes be evaluated, knowing that what comes out is non-tangible knowledge which itself is later used in other R&D processes in order to obtain real results? Moreover, what type of guidance is necessary in order make them work and obtain successful outcomes?
Come learn more and discuss with our speakers on December 2nd at 9am.
Moderator: Hugh LAVERTY, Senior Scientific Project Manager, IMI – Innovative Medicines Initiative (BE)
Speakers:
- Bernd STOWASSER, Head of Public Private Partnerships – External Innovation & Science Policy, Sanofi (DE)
- Nicolas CARBONI, President, SATT Conectus Alsace (FR)
- Jacky VONDERSCHER, President, Enyo Pharma (FR)
- Bruno FRANCOIS, Clinical Lead COMBACTE Consortium, CHU Limoges/Inserm (FR)
